tiprankstipranks
Advertisement
Advertisement
Sagimet Biosciences reports Q1 EPS (33c), consensus (35c)
PremiumThe FlySagimet Biosciences reports Q1 EPS (33c), consensus (35c)
12d ago
Sagimet Biosciences price target raised to $49 from $28 at Canaccord
Premium
The Fly
Sagimet Biosciences price target raised to $49 from $28 at Canaccord
21d ago
Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer
Premium
The Fly
Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer
23d ago
Sagimet Biosciences holds a conference call
PremiumThe FlySagimet Biosciences holds a conference call
26d ago
TD Cowen establishes $21 price target for Sagamet Bioscinces
Premium
The Fly
TD Cowen establishes $21 price target for Sagamet Bioscinces
26d ago
Sagimet Biosciences Announces Major Equity Offering for Pipeline
Premium
Company Announcements
Sagimet Biosciences Announces Major Equity Offering for Pipeline
26d ago
Sagimet Biosciences initiated with a Buy at Rodman & Renshaw
PremiumThe FlySagimet Biosciences initiated with a Buy at Rodman & Renshaw
2M ago
Sagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target
Premium
Ratings
Sagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target
2M ago
Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating
Premium
Ratings
Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100